Facebook
Twitter
LinkedIn
Forward
COVID-19: A Primer Update from Treatment to Long Haulers
Target Audience
This course is designed for healthcare workers of all specialties who are being impacted by COVID-19 and other chronic diseases, including physicians, research scientists, physician assistants, nurse practitioners, nurses, and anyone with a particular interest in prevention, treatment, and patient care.
Learning Objectives
- Review COVID-19 epidemiological data and at-risk populations.
- Analyze current treatment guidelines for acute COVID-19 infections.
- Review lifestyle tools to improve metabolic flexibility and immunocompetency.
- Synthesize the current research on available COVID-19 vaccines including risk/benefit and side effects.
- Examine the pathophysiology, diagnosis, and potential treatments for the COVID long-hauler population.
Additional Information
| Attachment | Size |
|---|---|
 COVID-19 Schedule.pdf | 164.45 KB |
| A Primer Update from Treatment to Long-Haulers 2021 Faculty Disclosures.pdf | 146.37 KB |
| David Brownstein, MD Dr. David Brownstein, M.D., is a board-certified family physician who utilizes the best of conventional and alternative therapies. He is the Medical Director for the Center for Holistic Medicine in West Bloomfield, Michigan. He is a graduate of the University of Michigan and Wayne State University School of Medicine. Dr. Brownstein is a member of the American Academy of Family Physicians and serves on the board for the International College of Integrative Medicine. He is the father of two beautiful physicians, Hailey and Jessica, and is a retired soccer coach. Dr. Brownstein has lectured internationally about his success using natural therapies. He has also authored sixteen books: Iodine: Why You Need It, Why You Can’t Live Without It, 5th Edition and his newest book, A Holistic Approach to Viruses. |
 | Panagis Galiatsatos, MD, MHS Panagis Galiatsatos, MD, MHS is an Assistant Professor at the Johns Hopkins School of Medicine in the Division of Pulmonary and Critical Care Medicine. He is co-chair of the Johns Hopkins Health Equity Steering Committee and is the co-director and co-founder of Medicine for the Greater Good, a novel medical initiative impacting over 10,000 Baltimore City lives in regards to health and wellness while at the same time creating physician-citizens. He has published over 60 research articles, with a focus on health equity, community engagement, and contextual-level variables impact on health outcomes, and is a co-author of the book series, "Building Health Communities". During the pandemic, Dr. Galiatsatos and colleagues coordinate community engagement to assure all populations were able to access COVID-19 updates and resources in an effort to assure compliance with public health requests. His clinical responsibilities center on critical care services in adult populations, Director of the Tobacco Treatment Clinic at Johns Hopkins Medicine, Associate Director of The Hereditary Hemorrhagic Telangiectasia Center of Clinical Excellence, and Physician in The Obstructive Lung Disease Group at Johns Hopkins Medicine and in the post-COVID-19 acute clinic. |
 | Leo Galland, MD Leo Galland, MD, a board-certified internist, practicing in New York City, is recognized as a world leader in functional and integrative medicine and a pioneer in the study of intestinal permeability and the gut microbiome as they impact immune function and systemic health. Educated at Harvard University and the NYU School of Medicine, he has received the Albert Norris Marquis Lifetime Achievement Award from Marquis Who’s Who for his contributions to medical innovation and the Linus Pauling Award from the Institute of Functional Medicine for developing basic principles of functional medicine. He is recognized in The Leading Physicians of the World and America’s Top Doctors. Dr. Galland has contributed to world medical literature with several dozen articles in scientific journals and chapters in medical textbooks. He created the section on Functional Foods for the Encyclopedia of Human Nutrition. An international best-selling author, Dr. Galland is frequently interviewed by major newspapers and news shows. His PBS Special, The Allergy Solution, aired over a thousand times. Since January, 2020, he has studied the covid-19 pandemic in depth, compiling his findings in an online, extensively referenced and free Coronavirus Guidebook. |
 | Sheldon Jordan, MD, FAAN, DABPN, DABCN, DABIPP Clinical Associate Professor of Neurology at UCLA and USC Adjunct Professor at Providence Saint John’s Research Center Medical Director of Regenesis CRO, Chief Investigator for 30 IRB Studies CEO of Synaptec Research, Synaptec Network and Synaptec Holdings Goldwin Scholar at UCLA, Winner of Upjohn Research Award and Surgical Medal. Elected Fellow of the American Academy of Neurology Editor and author of several medical textbooks, illustrator of several books, Numerous Art Exhibits Graduated from Brooklyn Tech in Industrial Design Attended University of Southampton, England in Shakespeare and Experimental Theater Graduated from Johns Hopkins University in Art, Psychology, Medical school requirements completed at Harvard. Medical School, Medicine and Neurology Post Graduate Studies and Fellowships at UCLA Governing Board of multiple medical professional organizations Board certified by American Board of Psychiatry and Neurology, American Board of Clinical Neurophysiology, American Board of Intervention Pain Medicine with additional certification in Regenerative Medicine. Certified by American Association of Neuroimaging in Magnetic Resonance Imaging, Computed Tomography and Ultrasonography. |
 | Dobri Kiprov, MD, HP (ASCP) Dobri Kiprov, MD, HP (ASCP) is internationally recognized as a pioneer and a leading expert in the field of Therapeutic Apheresis. Dr. Kiprov is the former Chief of the Division of lmmunotherapy at California Pacific Medical Center in San Francisco, California and the current Medical Director of Apheresis Care Group (ACG). He has worked in the field of therapeutic apheresis for more than 30 years and has published extensively on this subject. Dr. Kiprov served two terms on the American Society for Apheresis (ASFA) Board of Directors. Dr. Kiprov's extensive experience with immune system disorders has led to the development of therapeutic programs that foster immune system health and longevity through his unique approach. Dr. Kiprov is the recipient of multiple awards in recognition of his contributipn to the field of apheresis and immunology and he is the first physician to be Board Certified in Hemapheresis. Dr. Kiprov is currently involved in several immunology clinical trials. |
 | James LaValle, RPh, CCN, MT, DHM, DHPh James B. LaValle, R.Ph., C.C.N. M.T. DHM, DHPh., is an internationally recognized clinical pharmacist, author, and board-certified clinical nutritionist, with over 35 years of clinical experience. LaValle is best known for his expertise in performance health and integrative care with personally seeing thousands of clients over the years. He has an extensive background in natural products, lifestyle, drug/nutrient depletion, and uncovering the underlying metabolic issues that keep people from feeling healthy and vital. He has developed programs for several industries including fitness, professional sports teams and health care companies. Most recently Jim was appointed the Clinical Director of the Pro Football Hall of Fame Performance Health Program He taught for 15 years as an appointed adjunct faculty member at the University of Cincinnati College of Pharmacy pioneering the course “Survey of Natural Medicine”, served as faculty at the College of Medicine at U.C. all the while serving as a preceptorship for both physicians and pharmacy students. He is the founder of Metabolic Code Enterprises, a cloud-based assessment tool that helps to pinpoint where the metabolic roadblocks are to person’s health based on their symptom survey, lab markers, biometric and wearable data. The tool helps prioritize care for individuals using a point system to indicate areas of metabolism that are the most out of balance. The platform provides suggestions for dietary supplements, diet and other targeted lifestyle suggestions with the goal of building metabolic reserve, resiliency and vitality. In 2010, Jim developed personalized weight loss and wellness programs for LifeTime Fitness using his Metabolic Code approach for health and wellness. He and his team have also developed performance health programs for professional sports car racing, football, baseball, basketball, soccer and hockey players and teams, along with Olympic athletes. LaValle gained national recognition as National Clinician of the Year in 2012 by the Natural Products Association for his pioneering work in furthering the professional standards of integrative care. And in 2017 as Educator of the Year for American Academy of Anti-Aging Medicine. He is an appointed faculty member for the Integrative Medicine postgraduate program at George Washington University School of Health Sciences. As the Clinical Co-Chair at the American Academy of Anti-Aging Medicine, he has trained thousands of health care professionals on the value of predictive health and performance and modeling health care practices to incorporate lifestyle, diet and natural therapies as part of the health equation for Americans. He is author of more than 20 books including, “Cracking the Metabolic Code,” “Nutritional Cost of Drugs,” and his latest book, “Your Blood Never Lies”. In addition, he has authored 16 e-Books and four databases with information on a variety of topics, ranging from natural therapeutic decision tools, herb drug interactions, drug induced nutrient depletion, and professional monographs on 240 vitamin, mineral, nutraceutical and herbal compounds. He has also authored 200 articles, as well as being published in peer reviewed literature. Jim was named one of the “50 Most Influential Pharmacists” by American Druggist magazine and was one of nine Americans selected by Senator Tom Harkin, to participate in the inaugural Dietary Supplement Education Alliance & Dietary Supplement Information Bureau. As such, he is often called on by media for interviews on a variety of health topics due to his expertise and engaging style. |
 | Bruce David Levy, MD Dr. Levy is the Parker B. Francis Professor of Medicine at Harvard Medical School and Chief of the Pulmonary and Critical Care Medicine Division at Brigham and Women’s Hospital. Dr. Levy’s laboratory aims to identify new pathways to resolve pulmonary inflammation, infection or injury through the roles of naturally-derived, specialized pro-resolving mediators, and to translate these findings to the pathobiology of important airway diseases. His work has helped lead to more than 200 peer-reviewed publications, over 10 patents awarded or pending, and continuous funding from the National Institutes of Health since 1993. He is an active participant in NIH grant review study sections. He is an elected member of the ASCI, AAP and Interurban Clinical Club. He is active in the American Thoracic Society and currently serves as Chair of the Publication Policy Committee and a member of the Board of Directors. |
 | James Lyons-Weiler, PhD Dr. James Lyons-Weiler is a father, research scientist, author, and founder and CEO of the Institute for Pure and Applied Knowledge, also known as IPAK. He is Editor-in-Chief of the peer-reviewed journal, Science, Public Health Policy and the Law. He has over 20 years' experience as a biomedical and clinical research scientist. As an author, he has published three books, and over 58 research studies. With other scientists at IPAK, he performs research in the public interest aimed at finding ways to reduce human suffering. His latest research has focused on the accumulation of aluminum from pediatric vaccines, the discovery of chronic health issues associated with higher vaccine uptake and the role of autoreactogenic viral epitopes in the symptoms of COVID19 disease and COVID19 vaccine reactions. He is the architect of Plan B, a plan to replace the defunct public health system in the United States, host of the podcast Unbreaking Science. |
 | Peter McCullough, MD, MPH, FACP, FACC, FCCP, FAHA
After receiving a bachelor’s degree from Baylor University, Dr. McCullough completed his medical degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School in Dallas. He went on to complete his internal medicine residency at the University of Washington in Seattle, cardiology fellowship including service as Chief Fellow at William Beaumont Hospital, and master’s degree in public health at the University of Michigan. Dr. McCullough is a consultant cardiologist and Vice Chief of Medicine at Baylor University Medical Center in Dallas, TX. He is a Principal Faculty in internal medicine for the Texas A & M University Health Sciences Center. Dr. McCullough is an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state with > 1000 publications and > 500 citations in the National Library of Medicine. His works include the “Interface between Renal Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is a recipient of the Simon Dack Award from the American College of Cardiology and the International Vicenza Award in Critical Care Nephrology for his scholarship and research. Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an organization dedicated to bringing cardiologists and nephrologists together to work on the emerging problem of cardiorenal syndromes. His works have appeared in the New England Journal of Medicine, Journal of the American Medical Association, Lancet and other top-tier journals worldwide. He is the co-editor of Reviews in Cardiovascular Medicine, and associate editor of the American Journal of Cardiology and Cardiorenal Medicine. He serves on the editorial boards of multiple specialty journals. Dr. McCullough has made presentations on the advancement of medicine across the world and has been an invited lecturer at the New York Academy of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), European Medicines Agency, and the U.S. Congressional Oversight Panel. Major Contributions
|
| Andrew Pugliese, MD Dr. Pugliese received his doctorate from St. George’s University School of Medicine and completed his Infectious Disease Fellowship at Winthrop University Hospital. He is triple board certified in Internal Medicine, Infectious Disease, and Sleep Medicine. Dr. Pugliese runs an active blog named The ID Doc in which he address infectious disease, sleep, diet, overall health and healthcare topics. |
 | Ritchie Shoemaker, MD Dr. Ritchie Shoemaker is a 1973 of Duke University and a 1977 graduate of Duke Medical School, completing a Family Practice Residency at Williamsport Hospital in 1980. Dr. Shoemaker began his rural primary care family practice in Pocomoke, Maryland in 1980: where he lives today. Beginning with the outbreak of Pfiesteria Human Illness Syndrome in 1996, Dr. Shoemaker has devoted his career to unveiling the complexities of Chronic Inflammatory Response Syndrome—caused by exposure to damp buildings, cyanobacterial blooms, dinoflagellates, spirochetes, apicomplexans, and recluse spiders: among others. Dr. Shoemaker began the first biotoxin illness practice in the US in 2002, and has treated over 10,000 patients with CIRS illnesses. His non-profit research group, the Center for Research on Biotoxin Associated Illnesses, has raised over $2,000,000 for private funding of academic research. As a medical expert, Dr. Shoemaker has testified in over 200 cases. Shoemaker’s research has led to the publication of 11 books, several book chapters, and over forty peer-reviewed publications. His discovery of the role of VCS, HLA, MMP9, C4a, C3a, VEGF, TGF beta-1, NeuroQuant and several other biomarkers are widely used by healthcare practitioners across the country. Dr. Shoemaker has been training and certifying other healthcare providers since his medical retirement in 2012, and his lecture series now extends to Proficiency Partners through a 27-module training course and exam. In collaboration with Dr. James Ryan, Shoemaker is applying the once arcane field of differential gene activation to the primary care of CIRS patients. Dr. Ryan’s discovery of the role of hypometabolism in CIRS was a hallmark finding that underlies other chronic, fatiguing illnesses including CFS, fibromyalgia, and post-Lyme syndrome. Dr. Shoemaker has been recognized by Who’s Who in America for their distinguished career achievement award in 2018, and was additionally awarded Maryland’s Family Physician of the Year for 2001. Together with Paul Taylor and Debbie Waidner, Dr. Shoemaker has been instrumental in bringing the academic research basis for CIRS illnesses to the public via their website www.survivingmold.com. Dr. Shoemaker has been married to his wife JoAnn for 37 years. They have one child, Sally, who continues the family interest in photography and wetland education. |
 | Elisa Song, MD Dr. Elisa Song, MD is a holistic pediatrician, pediatric functional medicine expert, and mama. In her integrative pediatric practice, Whole Family Wellness (www.wholefamilywellness.org), she’s helped 1000s of kids get to the root causes of their health concerns and helped their parents understand how to help their children thrive – body, mind, and spirit – by integrating conventional pediatrics with functional medicine, homeopathy, acupuncture, herbal medicine, and essential oils. These health concerns have ranged from frequent colds, ear infections, asthma, and eczema; to autism, ADHD, anxiety, depression, and autoimmune illnesses. Dr. Song has taught around the world on integrative pediatrics topics for multiple podcasts and summits, including Fx Medicine Australia, BioCeuticals Australia, Integrative Medicine for Mental Health, The Center for Education and Development of Clinical Homeopathy, Academy for Pain Research, Center for Advanced Acupuncture Pediatrics, Institute for Functional Medicine, and Holistic Pediatric Association. Dr. Song created Healthy Kids Happy Kids (www.healthykidshappykids.com) as an online holistic pediatric resource to help practitioners and parents bridge the gap between conventional and integrative pediatrics with an evidence-based, pediatrician-backed approach. |
 | Pam Taub, MD, FACC, FAPSC Associate Professor of Medicine Pam Taub, MD is a board-certified cardiologist and founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center at UC San Diego. Dr. Taub was responsible for all aspects of creating the center, which provides a comprehensive cardiac rehabilitation program for patients with established heart disease. Her clinical practice focuses on preventive cardiology, lipidology, as well as women's cardiovascular health. She has extensive clinical trial experience and is active in clinical and translational research. Her research focuses on assessing the impact of behavioral, technological, and pharmacological interventions on cardiometabolic disease. Dr. Taub's is a federally funded researcher with funding from: the National Institutes of Health (Principal Investigator on R01 grant), Department of Defense, Department of Homeland Security and American Heart Association. Dr. Taub is widely published (with over 100 publications, books chapters and abstracts) and has authored high impact publications in top peer-reviewed journals including Cell Metabolism and the Journal of the American College of Cardiology. Dr. Taub holds multiple leadership positions in professional societies, serving as a fellow and board member for the American Society of Preventive Cardiology. She is a fellow and member of the American College of Cardiology Prevention of CV Disease Section Leadership Council. She also serves on American Heart Association Council on Clinical Cardiology (Women in Cardiology Committee). Dr. Taub received her MD from Boston University School of Medicine. She completed her residency in internal medicine at the University of Washington Medical Center in Seattle and her fellowship in cardiovascular medicine at UC San Diego. She is board certified in internal medicine, cardiovascular disease. |
Available Credit
- 16.00 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 16.00 Completion
Required Hardware/software
Technical Requirements:
- High-speed internet connection
- Browsers:
- This educational activity has been tested in the latest versions of Internet Explorer, Edge, Firefox, Safari, and Chrome browsers on Windows or Macintosh computers.
- Safari, Firefox, or Chrome browsers are recommended for the best results.
- Internet Explorer browser is not recommended. If you must use Internet Explorer, please update to version 11, which is the only version supported by Microsoft at this writing.
- Latest version of Adobe Reader to view PDF documents.